Estrogen replacement therapy and longitudinal decline in visual memory: A possible protective effect?

Neurology

Volumn 49, Issue 6, 1997, Pages 1491-1497

  Resnick, Susan M ^a,b   Metter, E Jeffrey ^a   Zonderman, Alan B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; AGING; ARTICLE; COGNITION; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTECTION; SHORT TERM MEMORY; VISUAL MEMORY;

EID: 0031439414     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.6.1491     Document Type: Article

References (55)

1. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wison PWF, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329: 1141-1146.
2. Cauley JR, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995;122:9-16.
3. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;265:1861-1867.
4. Stampfer MJ, Colitz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325:756-762.
5. Sherwin BB. Estrogenic effects on memory in women. Ann NY Acad Sci 1994;743:213-231.
6. Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87:20S-26S.
7. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140: 256-261.
8. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and non-demented control subjects. Arch Neurol 1994;51:896-900.
9. Tang M-X, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
10. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
11. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986;11:337-345.
12. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). J Steroid Biochem 1989;34:521-525.
13. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994;41:361-371.
14. Hampson E. Estrogen-related cognitive abilities across the menstrual cycle. Brain Cogn 1990;14:26-43.
15. Phillips SM, Sherwin BB. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 1992;17:497-506.
16. Hackman BW, Galbraith D. Replacement therapy with piperazine oestrone sulfate ("Harmogen") and its effect on memory. Curr Med Res Opin 1976;4:303-328.
17. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977;4:31-47.
18. Fedor-Freybergh P. The influence of oestrogens on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynaecol Scand 1977;64:5-64.
19. Vanhulle G, Demel R. A double-blind study into the influence of estriol on a number of psychological tests in postmenopausal women. In: van Keep PA, Greenblatt RB, Albeaux-Fernet M, eds. Consensus on the menopause research. London: MTP Press, 1976:94-99.
20. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357.
21. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
22. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994;83: 979-983.
23. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-922.
24. Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 1995;29:312-321.
25. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637-2641.
26. Shock NW, Greulich RC, Andres R, et al. Normal human aging: the Baltimore Longitudinal Study of Aging. Washington, DC: US Government Printing Office, 1984.
27. Arenberg D. Differences and changes with age in the Benton Visual Retention Test. J Gerontol 1978;33:534-540.
28. Giambra LM, Arenberg D, Zonderman AB, Kawas C, Costa PT Jr. Adult life span changes in immediate visual memory and verbal intelligence. Psychol Aging 1995;10:123-139.
29. Resnick SM, Trotman KM, Kawas C, Zonderman AB. Age-associated changes in specific errors on the Benton Visual Retention Test. J Gerontol Psychol Sci 1995;50B:P171-P178.
30. Schichita K, Hatano S, Ohashi Y, Shibata H, Matuzaki T. Memory changes in the Benton Visual Retention Test between ages 70 and 75. J Gerontol 1986;41:385-386.
31. Benton AL, Eslinger PJ, Damasio AR. Normative observations on neuropsychological test performances in old age. J Clin Neuropsychol 1981;3:33-42.
32. Zonderman AB, Giambra LM, Kawas CH, Arenberg D, Resnick SM, Costa PTJ. Changes in immediate visual memory predict cognitive impairment. Arch Clin Neuropsychol 1995;10:111-123.
33. Benton AL. The Revised Visual Retention Test: clinical and experimental applications. 3rd ed. New York: Psychological Corp., 1963.
34. Benton AL. Revised Visual Retention Test. New York: Psychological Corp., 1974.
35. Hays WL. Statistics for the social sciences. New York: Holt, Rinehart and Winston, 1973.
36. Rauramo L, Lagerspetz K, Engblom P, Punnonen R. The effect of castration and peroral estrogen therapy on some psychological functions. Front Horm Res Basel: Karger, 1975:94-104.
37. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 1995;7:334-337.
38. Woolley CS, Gould E, Frankfurt M, McEwen BS. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990;10:4035-4039.
39. Schneider LS, Farlow MS, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996;46:1580-1584.
40. Squire LR, Butters N. Neuropsychology of memory. New York: Guilford Press, 1992.
41. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
42. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769-772.
43. McEwen BS, Woolley CS. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994;29:431-436.
44. Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286-1291.
45. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 1994;14:7680-7687.
46. Nehlig A, Porrino LJ, Crane AM, Sokoloff L. Local cerebral glucose utilization in normal female rats: variations during the estrous cycle and comparison with males. J Cerebr Blood Flow Metabol 1985;5:393-400.
47. Namba H, Sokoloff L. Acute administration of high doses of estrogen increases glucose utilization throughout brain. Brain Res 1984;291:391-394.
48. Bishop J, Simpkins JW. Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res Bull 1994;36:315-320.
49. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-490.
50. Toran-Allerand CD, Miranda RC, Bentham WDL, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992;89:4668-4672.
51. Behl C, Widmann M, Trapp T, Holsboer F. 17-B estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995;216:473-482.
52. Murphy DGM, DeCarli C, Daly E, et al. X-chromosome effects on female brain: a magnetic resonance imaging study of Turner's syndrome. Lancet 1993;342:1197-1200.
53. Bondi MW, Monsch AU, Galasko D, Butters N, Salmon DP, Delis DC. Preclinical markers of dementia of the Alzheimer type. Neuropsychology 1994;8:374-383.
54. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994;44:1427-1432.
55. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 1996;275:528-532.